Copy For Citation
Tugcu M., Kasapoglu U., Boynuegri B., Can O., Gokce A. M., Ruhi C., ...More
TRANSPLANTATION PROCEEDINGS, vol.47, no.5, pp.1528-1530, 2015 (SCI-Expanded)
Article / Article
Science Citation Index Expanded (SCI-EXPANDED), Scopus
Acibadem Mehmet Ali Aydinlar University Affiliated:
Background. New-onset diabetes after transplantation (NODAT) is a common metabolic complication. Most conventional immunosuppressive medications, especially steroids and tacrolimus, are responsible for its development. NODAT may rarely be associated with severe, life-threating complications in kidney transplantation recipients.